Renal cachexia. Professor Joanne Reid
|
|
- Dora Rose
- 5 years ago
- Views:
Transcription
1 Renal cachexia Professor Joanne Reid
2
3 Cachexia Cachexia is a complex metabolic syndrome associated with underlying illness and characterised by muscle loss, with or without loss of fat Definition of cachexia in chronic illness weight loss of at least 5% within 12 months or Body Mass Index (BMI) <20 kg/m 2 plus three of the following five features: decreased muscle strength; fatigue; anorexia; low fat-free mass index; abnormal biochemistry (increased inflammatory markers [CRP, IL-6], anaemia [Hb <120 g/l], low serum albumin [<32g/L] (Evans et al. 2008). Evans et al. (2008). Cachexia, a new definition. Clinical Nutrition 27,
4 Pathogenesis of cachexia Evans et al. (2008). Cachexia, a new definition. Clinical Nutrition 27,
5 Why is it important to investigate cachexia? Cachexia is linked with poor outcomes for the patients Presence of the cachectic syndrome, associated with any chronic disease trajectory, increases mortality Cachexia causes great morbidity, limits therapy No standardised best treatment for cachexia Lack of guidelines / protocols in clinical practice
6 Living with cancer cachexia: Exploring the perspectives of patients and their significant others
7 Summary findings Summary findings QUB Heritage
8 Conclusions Conclusions: in-depth understanding for patients with cancer and their families challenges that they face on a daily basis new knowledge on our awareness and comprehension of the experience of cachexia Further research: develop interventions that have therapeutic impact for patients with cachexia and their families
9 Practice and policy impact National level - (Royal College of Nursing) Getting it right every time: Nutrition and Hydration Care at end of life (
10 Thalidomide For Managing Cancer Cachexia European level - European Society for Clinical Nutrition and Metabolism (ESPEN) ESPEN guidelines on nutrition in cancer patients
11 Practice and policy impact BRITISH COLUMBIA INTER-PROFESSIONAL PALLIATIVE SYMPTOM MANAGEMENT GUIDELINES (2017)
12 Health care professionals experience, understanding and perception of need of advanced cancer patients with cachexia and their families: The benefits of a dedicated clinic
13 Study Findings Need to develop specialist communication skills training for healthcare professionals Care of patients with cachexia and their families should employ a multidisciplinary approach Implications for practice: A formal educational cancer cachexia programme for clinicians A dedicated clinic can facilitate a learning environment that allowed best practice to develop across and between professional groups
14 QUB Heritage Importance of the problem: renal disease
15 Importance of problem renal cachexia? Between 30-60% of advanced CKD patients will have cachexia Limited attention has been devoted to cachexia in renal disease For renal cachexia there are no standardised definitions or inclusion criteria to help inform practice or research
16 Management of cachexia Challenging definition needs refinement for renal population Discriminating cachexia from other causes of malnutrition Clinically differentiate between Cachexia and Protein Energy Wasting as each state may require distinct management strategies
17 Renal cachexia work completed Belfast based working group established Review paper: Reid et al. (2013). A literature review of end-stage renal disease and cachexia: understanding experience to inform evidence-based healthcare. Journal of Renal Care 39(1), Workshops (funding secured through R&D Office) 1)Belfast to UK working group (BRS conference, 2014) 2)UK to International working group (Belfast workshop, 2014) Consensus of defining foci and forward planning Editorial: Reid et al (2015) Defining cachexia in a renal population. J of Renal Care 2016 (differentiating between cachexia, sarcopenia and PEW) JHPC. Includes colleagues from UK, USA and Europe Study funded (Public Health Agency / NI Kidney Research Fund) 1)Establishing a clinical phenotype for cachexia in ESRD recruitment completed 04/2018 2)Protocol published BMC Nephrology 2018; 19: 38 3)Publish review prior to cross-sectional results JCSM 4)Cross-sectional papers cachexia / LMM measurement / QoL
18 Publications Blog: Evidence based nursing: Cachexia and it s impact on people with renal disease: Posted on December 15, 2014 Reid, J, Noble, HR, Porter, S, Shields, JS & Maxwell, AP 2013, 'A literature review of endstage renal disease and cachexia: Understanding experience to inform evidence-based healthcare' Journal of Renal Care, DOI: /j x Reid, J, Noble, H, Davenport, A, Farrington, K, Fouque, D, Porter, S, Seres, D, Shields, J, Slee, A, Witham, MD, Wright, M & Maxwell, AP 2015, 'Defining cachexia in a renal population' Journal of Renal Care, DOI: /jorc Slee A, Reid J (accepted) Wasting in chronic kidney disease: a complex issue. JCSM clinical Reports Reid, J, Noble, HR, Slee, A, Davenport, A, Farrington, K, Fouque, D, Kalantar-Zadeh, K, Porter, S, Seres, D, Withman, MD & Maxwell, AP 2016, 'Distinguishing Between Cachexia, Sarcopenia and Protein Energy Wasting in End-Stage Renal Disease Patients on Dialysis' Palliative Medicine and Hospice Care, vol. 2, no. 2, pp. e11 - e13. DOI: /PMHCOJ-2-e004 Establishing a clinical phenotype for cachexia in end stage kidney disease study protocol Joanne Reid, Helen R. Noble, Gary Adamson, Andrew Davenport, Ken Farrington, Denis Fouque, Kamyar Kalantar-Zadeh, John Mallett, C. McKeaveney, S. Porter, David S. Seres, Joanne Shields, Adrian Slee, Miles D. Witham, and Alexander P. Maxwell doi: /s
19 Working group/collaborators Belfast Based Team Professor Joanne Reid - QUB Dr Helen Noble - QUB Professor Sam Porter Bournemouth University Dr Joanne Shields - BHSCT Dr Adrian Slee UCL Professor Peter Maxwell - BHSCT / QUB Current working group Professor Denis Fouque - France Professor Ken Farrington England Dr Andrew Davenport - England Dr Miles Whitman - Scotland Dr David Seres USA Professor Kamyar Kalantar-Zadeh - USA Professor Donal O Donoghue Manchester University
20 Working group/collaborators Belfast Based Team Professor Joanne Reid - QUB Dr Helen Noble - QUB Professor Sam Porter Bournemouth University Dr Joanne Shields - BHSCT Dr Adrian Slee UCL Professor Gary Adamson UU Dr John Mallett Professor Peter Maxwell - BHSCT / QUB Current working group Professor Denis Fouque - France Professor Ken Farrington England Dr Andrew Davenport - England Dr Miles Whitman - Scotland Dr David Seres USA Professor Kamyar Kalantar-Zadeh - USA Professor Donal O Donoghue Manchester University
21
22 Establishing A Clinical Phenotype For Cachexia In End-stage Kidney Disease
23 Background Aim: The aim of this study is to determine the clinical phenotype of cachexia specific to individuals with ESKD. Method: This is a longitudinal study which will run over two years. Recruitment: 106 adult haemodialysis patients using a Regional Nephrology Service in the U.K. with a confirmed diagnosis of stage 5 CKD (beginning dialysis at an estimated GFR <15 ml/min/1.73m 2 ). Data Collection: Patients are followed 2 monthly over 12 months and recorded measurements of weight; lean muscle mass (bioelectrical impedance, mid upper arm muscle circumference - from measures of mid arm circumference and tricep skin fold thickness); muscle strength (hand held dynamometer) and increased inflammatory markers (CRP >5mg/L); anaemia (haemoglobin <120 g/l); low serum albumin (<32g/L). Questionnaires: QoL (KDQoL), Fatigue (FACIT) and Anorexia (FAACT) recorded every two months. Primary renal disease, dialysis vintage and co-morbidities (Charlson Comorbidity Index) were also analysed.
24
25 Decreased muscle strength (Dynamometer) Abnormal biochemistry Increased CRP Low albumin Low Haemoglobin Lean muscle loss (MUA & TSF) Fatigue (FACIT) Questionnaire Anorexia (FAACT) Questionnaire
26 Baseline findings: primary criteria No Weight loss Weight loss of at least 5% 6 months or at least 10% 12 months or Body Mass Index (BMI) <20 kg/m 2 Weight loss (<5% over 6 months or <10% over 12 months) Weight loss (>5% over 6 months or >10% over 12 months) <6 patients <20kg/m 2 Average BMI Male Female No Weight loss <5% or <10% >5% or >10% 23 22
27 Table 1: Baseline findings (Males) Plus three of the following five features: * * decreased muscle strength fatigue anorexia low fat-free mass index inflammatory markers (CRP) low serum albumin anaemia * significant
28 Table 2: Baseline findings (Females) Plus three of the following five features: * decreased muscle strength fatigue anorexia low fat-free mass index inflammatory markers (CRP) low serum albumin anaemia * significant
29 Table 3: Quality of Life (KDQoL)
30 Role of primary renal disease, dialysis vintage and co-morbidities
31 QUB Heritage Study in collaboration with EDTNA/ERCA
32 Research protocol: Awareness, understanding and treatment practices among health care professionals involved in managing cachexia in patients with End-stage kidney disease. While progress has been made in exploring the awareness, understanding and treatment practices of health care professionals who manage cachexia in other chronic illnesses, no study has explored this for cachexia in renal disease The importance of this work is underscored by the negative impact that symptoms of cachexia have on quality of life and the association of cachexia with a substantially increased risk of premature mortality The study is being conducted with the European Dialysis and Transplant Nurses Association/European Renal Care Association (EDTNA/ERCA) The EDTNA/ERCA is a European network established in 1971 to address the educational needs of nurses and other healthcare professionals caring for patients who suffer from Chronic Kidney Disease. EDTNA/ERCA is a multi-disciplinary organisation with membership open to nurses, technicians, social workers, dietitians, unit managers, transplant coordinators, and other professionals working with patients with kidney disease.
33 A STUDY TO GAIN INSIGHTS INTO THE AWARENESS, UNDERSTANDING AND TREATMENT PRACTICES AMONG HEALTH CARE PROFESSIONALS INVOLVED IN MANAGING CACHEXIA IN PATIENTS WITH END STAGE RENAL DISEASE Survey open to all EDNTA / ERCA members The information will help us understand the management of cachexia in renal disease. Participation is completely anonymous. The survey takes approximately 20 minutes to complete. Membership with EDTNA/ERCA will not be affected whether you choose to participate or not. Return of the questionnaire is considered your consent to participate in this research. Click the link below to be taken to the survey or scan the QR code. If you are not able to get to the survey, please copy and paste the link into your internet browser. In -depth focus groups
34 Data collection so far. Ongoing survey remains open 1 focus group to complete Survey results so far Responses from 22 countries worldwide Mostly female Excellent range of experience in renal speciality (>50% have over 15 years experience) Lack of certainty about weight loss associated with cachexia Importance of treatment with focus on QoL and family distress Need for disease specific definition to facilitate diagnosis and treatment evident
35 QUB Heritage Renal cachexia research: next steps
36 Definition and intervention A clinical phenotype of cachexia would help to provide early recognition, prevention and timely-appropriate treatment of this devastating condition. Therapeutic approach is dependent on correct classification. Identify to treat Develop an intervention to treat cachexia in renal population Currently no licensed treatment for cachexia in ESRD No accepted standard of care Multi-modal intervention Cachexia is a multifactorial syndrome Lends itself to therapeutic targeting through multimodal treatment
37 Intervention components: Aim - to stop / prevent muscle loss and improve physical function Optimising food intake has been advocated as a key modality in the treatment of cancer cachexia Inflammation is one of the main pathophysiological drivers in cachexia. Thus attenuation of the pro-inflammatory response has been argued as a key component of any cachexia therapy.
38 Qualitative research: enhance person centred care Qualitative research is able to capture the experience of illness, and enables professionals and providers to understand how individuals perceive illness
39 Renal cachexia research: Implications for practice and policy Phenomenon continues to be under-recognised and under-treated in clinical practice Exploring the awareness, understanding and current treatment practices of renal cachexia is currently underway May identify need for similar educational support and development in cancer cachexia Clinical trials (robust pharma and non-pharma) New knowledge gained from this research will inform and develop future care management strategies in the delivery of evidence-based holistic services to this complex patient population Quality Improvement: Implementation of appropriate weight surveillance for clinicians e.g. handgrip strength, BIA? Unaddressed holistic difficulties Role for education?
40 Thank You Any questions?
41
Malnutrition in advanced CKD
Malnutrition in advanced CKD Malnutrition Lack of proper nutrition, caused by not having enough to eat, not eating enough of the right things or being unable to use the food that one does eat Jessica Stevenson
More informationEnd stage renal disease and Protein Energy wasting
End stage renal disease and Protein Energy wasting Dr Goh Heong Keong MBBS,MRCP(UK) www.passpaces.com/kidney.htm Introduction Chronic kidney disease- increasing health burden in many countries. The estimated
More informationCancer cachexia: assessment and classification. KCH Fearon University of Edinburgh Scotland
Cancer cachexia: assessment and classification KCH Fearon University of Edinburgh Scotland 1 What is the cancer cachexia phenotype?...the shoulders, clavicles, chest and thighs melt away. This illness
More informationNutrition Assessment in CKD
Nutrition Assessment in CKD Shiaw-Wen Chien, MD, EMBA Division of Nephrology, Department of Medicine, Tungs Taichung MetroHarbor Hospital Taichung, Taiwan September 10, 2017 Outline Introduction Composite
More informationClinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia
Clinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia Stéphane M. Schneider, MD, PhD, FEBGH Professor of Nutrition and ESPEN ECPC Chair In proto-indo-european, Latin and Greek Under
More informationDESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for
DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards
More informationLa relation dialyse et nutrition
Nutrition en dialyse : controverses La relation dialyse et nutrition Charles Chazot, MD NephroCare Tassin-Charcot Sainte Foy Les Lyon, France HEMO study lessons (1) Dose Body weight flux Rocco, Kidney
More informationHorizon Scanning Centre November Enobosarm (Ostarine) for cachexia in patients with advanced non-small cell lung cancer first line
Horizon Scanning Centre November 2012 Enobosarm (Ostarine) for cachexia in patients with advanced non-small cell lung cancer first line SUMMARY NIHR HSC ID: 5206 This briefing is based on information available
More informationAcceptance onto Dialysis Guidelines
Guidelines John Kelly (Kogarah, New South Wales) Melissa Stanley (Melbourne, Victoria) David Harris (Westmead, New South Wales) Date written: December 2004 Final submission: June 2005 Predialysis education
More informationGlobal Leadership Initiative in Malnutrition (GLIM): Global Consensus on Malnutrition Diagnostic Criteria Harriët Jager-Wittenaar, PhD, MD
Global Leadership Initiative in Malnutrition (GLIM): Global Consensus on Malnutrition Diagnostic Criteria Harriët Jager-Wittenaar, PhD, MD Professor (Lector) of Malnutrition and Healthy Ageing Global Leadership
More informationRESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016
RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney
More informationPalliative and End of Life Care in End Stage Renal Disease
Palliative and End of Life Care in End Stage Renal Disease Palliative and End of Life Care Priority for Action Regional Consensus Workshop 30.06.2010 Neal Morgan Consultant Nephrologist SHSCT Outline Introduction
More informationChapter 25: Interactions of Dialysis Teams With Geriatricians
Chapter 25: Interactions of Dialysis Teams With Geriatricians Nicole Stankus* and Kellie Campbell *Section of Nephrology, University of Chicago, Chicago, Illinois; and Section of Geriatrics, University
More informationNew global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries
New global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries An estimated 1 in 10 people worldwide have chronic kidney disease **Embargo: 18:00H
More informationAspetti nutrizionali nel paziente in emodialisi cronica
Aspetti nutrizionali nel paziente in emodialisi cronica Enrico Fiaccadori enrico.fiaccadori@unipr.it Università degli Studi di Parma Agenda Diagnosis of protein-energy wasting (PEW) in ESRD on HD Epidemiology
More informationDoes Hemodialysis or Peritoneal Dialysis Provide a Better Quality of Life for Those with Chronic Kidney Disease? University of New Hampshire
Running head: QUALITY OF LIFE AMONG CKD PATIENTS Does Hemodialysis or Peritoneal Dialysis Provide a Better Quality of Life for Those with Chronic Kidney Disease? University of New Hampshire QUALITY OF
More informationThe use of omega-3 fatty acids in the management of cancer cachexia. Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust
The use of omega-3 fatty acids in the management of cancer cachexia Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust Overview Cancer cachexia Clinical features Pathogenesis
More informationMeasure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes
Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationThe Health Problem: Guidelines: NHS Priority:
PRIORITY BRIEFING The purpose of this briefing paper is to aid Stakeholders in prioritising topics to be taken further by PenCLAHRC as the basis for a specific evaluation or implementation research project.
More informationActivity Report July 2012 June 2013
Urological Cancers Managed Clinical Network Activity Report July 2012 June 2013 Mr Seamus Teahan Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationProfessor Suetonia Palmer
Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS
More informationScreening and early recognition of CKD. John Ngigi (FISN) Kidney specialist
Screening and early recognition of CKD John Ngigi (FISN) Kidney specialist screening Why? Who? When? How? Primary diagnosis for patients who start dialysis Other 10% Glomerulonephritis 13% No. of dialysis
More informationApplying clinical guidelines treating and managing CKD
Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012
More informationGeriatric Nephrology. Murtener Tage
Geriatric Nephrology Murtener Tage 2014 Isabelle.Binet@kssg.ch www.nierenstiftung.ch Plan Geriatric nephrology The elderly with CKD The elderly on dialysis The elderly in transplantation Plan Geriatric
More information1. Default Section. 1. Gender: 2. Credentials (mark all that apply):
1. Default Section 1. Gender: Male Female 2. Credentials (mark all that apply): RD LD/CDN Master s PhD RN CSR CDE CNSC 3. How long have you been practicing as a Registered Dietitian? (If you are not currently
More informationPrevalence of malnutrition in dialysis
ESPEN Congress Cannes 2003 Organised by the Israel Society for Clinical Nutrition Education and Clinical Practice Programme Session: Nutrition and the Kidney Malnutrition and Haemodialysis Doctor Noël
More informationEvaluation of body composition monitor for assessment of nutritional status in hemodialysis patients
Evaluation of body composition monitor for assessment of nutritional status in hemodialysis patients Zhang Haifen, Shi Ling, Jiang Na, Yang Yan, Tao Xingjuan Renji Hospital Shanghai Jiao Tong University
More informationCONSERVATIVE KIDNEY MANAGEMENT GUIDELINES
30 th Nov 2010.. Page No 1. Number of Policy 31.> 1 Nephrology, Urology and Transplantation Directorate CONSERVATIVE KIDNEY MANAGEMENT GUIDELINES Document Number: 31 Original Date of Approval: 30 th Nov
More informationAcceptance onto dialysis guidelines: St George Hospital
Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines
More informationAlterazioni metaboliche e nutrizionali in corso di artrite reumatoide e malattie autoimmuni Alessio Molfino, MD, PhD
Alterazioni metaboliche e nutrizionali in corso di artrite reumatoide e malattie autoimmuni Alessio Molfino, MD, PhD Direttore: Prof. Filippo Rossi Fanelli alessio.molfino@uniroma1.it Rheumatoid arthritis
More informationA Framework for Optimal Cancer Care Pathways in Practice
A to Guide Care Cancer Care A for Care in Practice SUPPORTING CONTINUOUS IMPROVEMENT IN CANCER CARE Developed by the National Cancer Expert Reference Group to support the early adoption of the A to Guide
More informationTHE CONSERVATIVE CARE PATHWAY
THE CONSERVATIVE CARE PATHWAY Dr. Gaylene Hargrove Sept. 19, 2015 Island Health Renal Program End of Life Conference Learning Objectives Describe and discuss what defines conservative care. Identify key
More informationThe Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks
The Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks Royal College of Physicians of Edinburgh Friday 12 October 2007 CONTENTS 1.0 ACCOUNTABILITY AND ORGANISATION 2.0
More informationSingle Technology Appraisal (STA) Anamorelin for treating cachexia and anorexia in people with non-small-cell lung cancer
Single Technology Appraisal (STA) Anamorelin for treating cachexia and anorexia in people with non-small-cell Response to consultee and commentator comments on the draft remit and draft scope (pre-referral)
More informationNutritional requirements in advanced cancer patients
Nutritional requirements in advanced cancer patients Paula Ravasco p.ravasco@fmedicina.ulisboa.pt Laboratory of Nutrition Faculty of Medicine of the University of Lisbon Medical School of Lisbon Portugal
More informationPr Denis FOUQUE. Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France
Pr Denis FOUQUE Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France Observatoire Phosphocalcique, January 2011 1200 36.1 ± 5.0 g/l 1050 900 PEW
More informationDietetic Outcomes in Home Parenteral Nutrition
Dietetic Outcomes in Home Parenteral Nutrition Dr Alison Culkin Research Dietitian Intestinal Failure & Home Parenteral Nutrition St Mark s Hospital PENG Meeting November 2011 The Dietetic Outcomes Model
More informationNutrition to Support Symptom Management. Ann-Maree Randall Dietitian, RSC Nepean Hub
Nutrition to Support Symptom Management Ann-Maree Randall Dietitian, RSC Nepean Hub Malnutrition in RSC across NSW Malnutrition prevalence 48% conservative care 59% symptom support Change in nutritional
More informationSERVICE SPECIFICATION 6 Conservative Management & End of Life Care
SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationUK Renal Registry. 18th Annual Report
The Renal Association UK Renal Registry Learning and Research Building Southmead Hospital, Southmead Road Bristol BS10 5NB UK Telephone + 44 (0) 117 414 8150 Email renalregistry@renalregistry.nhs.uk Web
More informationDedicated to research, education and service to patients for prevention and effective treatment of kidney disease
STRATEGIC PLAN Our Mission: Dedicated to research, education and service to patients for prevention and effective treatment of kidney disease Introduction Over the last 2 years, the Trustees undertook
More informationProspectus September Education, Innovation & Research (EIR) Department. Caring, Building, Shaping, Valuing, Inspiring, Encouraging, Developing,
Education, Innovation & Research (EIR) Department Prospectus 2017 Caring, Building, Shaping, Valuing, Inspiring, Encouraging, Developing, 0 P a g e Nurturing, Supporting, Motivating, Engaging and Communicating
More informationEvaluation and management of nutrition in children
Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence
More informationCKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry. UK Renal Registry 2013 Annual Audit Meeting
CKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry UK Renal Registry 2013 Annual Audit Meeting Scope of the talk Background CK MAPPS EQUAL My Research Future
More informationBuilding on Success. Driving improvements in clinical outcomes through a Greater Manchester Cancer Alliance. May 2015
Building on Success Driving improvements in clinical outcomes through a Greater Manchester Cancer Alliance May 2015 Introduction Cancer care in Greater Manchester has seen significant improvements in recent
More informationNutrition and Renal Disease Update
Nutrition and Renal Disease Update Denis FOUQUE Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France What have we learned? 1. Chronic kidney disease:
More information21th Budapest Nephrology School Ágnes Haris, Kálmán Polner
21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with
More informationEpidemiology, Diagnostic and treatment for Protein Energy Wasting in Dialysis
Epidemiology, Diagnostic and treatment for Protein Energy Wasting in Dialysis Pr Denis FOUQUE Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France ESRD
More informationRole of High-sensitivity C-reactive Protein as a Marker of Inflammation in Pre-dialysis Patients of Chronic Renal Failure
ORIGINAL ARTICLE JIACM 2009; 10(1 & 2): 18-22 Abstract Role of High-sensitivity C-reactive Protein as a Marker of Inflammation in Pre-dialysis Patients of Chronic Renal Failure N Nand*, HK Aggarwal**,
More informationNutrition in hemodialysis patients with focus on Intradialytic Parenteral Nutrition (IDPN)
Nutrition in hemodialysis patients with focus on Intradialytic Parenteral Nutrition (IDPN) Enrico Fiaccadori enrico.fiaccadori@unipr.it Acute and Chronic Renal Failure Unit Medicine & Surgery Dept. Parma
More informationRESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016
RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney
More informationKDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology
KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology September 8-11, 2016 Paris, France Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization
More informationRenal Supportive Care. Renal Supportive Care Symposium 2013 Elizabeth Josland CNC
Renal Supportive Care. Renal Supportive Care Symposium 2013 Elizabeth Josland CNC Outline Background of Renal Supportive Care Conservative Management Symptom overview Reading What does conservative management
More informationKrediet slide di 18
1 di 18 Assessment of fluid status in PD patients Raymond T. Krediet, Amsterdam, Netherlands Chairs:Walther H. Boer, Utrecht, The Netherlands F. Fevzi Ersoy, Antalya, Turkey Prof. Raymond T. Krediet DDivision
More informationCommunity and Mental Health Services. Palliative Care. Criteria and
Community and Mental Health Services Specialist Palliative Care Service Referral Criteria and Guidance November 2018 Specialist Palliative Care Service Referrals These guidelines cover referrals for patients
More informationSouth East Coast Operational Delivery Network. Critical Care Rehabilitation
South East Coast Operational Delivery Networks Hosted by Medway Foundation Trust South East Coast Operational Delivery Network Background Critical Care Rehabilitation The optimisation of recovery from
More informationNational Chronic Kidney Disease Audit
National Chronic Kidney Disease Audit // National Report: Part 2 December 2017 Commissioned by: Delivered by: // Foreword by Fiona Loud And if, as part of good, patient-centred care, a record of your condition(s),
More informationIntradialytic Parenteral Nutrition in Hemodialysis Patients. Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia
Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia Disclosure Information Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy
More informationDelivering personalised care to end of life patients. Jane Naismith Nurse Consultant in Palliative care St Joseph s Hospice London
Delivering personalised care to end of life patients Jane Naismith Nurse Consultant in Palliative care St Joseph s Hospice London Over View This session will cover Supporting patients with long term conditions
More informationKidney Patients with Chronic Kidney Disease
Cheshire and Merseyside Kidney Care Services Renal Replacement Therapy Options for Kidney Patients with Chronic Kidney Disease Stage 5 Renal Replacement Therapy Options for Kidney Patients with Chronic
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES
Date written: September 2004 Final submission: February 2005 Other criteria for starting dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationA06/S(HSS)b Ex-vivo partial nephrectomy service (Adult)
A06/S(HSS)b 2013/14 NHS STANDARD CONTRACT FOR EX-VIVO PARTIAL NEPHRECTOMY SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATION Service Specification No. Service Commissioner
More informationESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Multimodal therapy of cancer cachexia K. Fearon (UK)
ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER Multimodal therapy of cancer cachexia K. Fearon (UK) Multimodal therapy for cancer cachexia KCH Fearon Learning objectives Understand
More informationESPEN Congress Copenhagen 2016
ESPEN Congress Copenhagen 2016 THE DIVERSITY OF OBESITY MALNUTRITION IN THE OBESE R. Barazzoni (IT) Malnutrition in the obese patient Rocco Barazzoni Dept of Medical, Surgical and Health Sciences University
More informationSouth Belfast Integrated Care Partnership. Transforming Delivery of Diabetes Care 2014
South Belfast Integrated Care Partnership Transforming Delivery of Diabetes Care 2014 Background Context: Aims: Reduction in T2DM Earlier recognition of Type 1 diabetes in children Reduction in risk and
More informationMolecular Mechanisms associated with the Cancer-Cachexia Syndrome
Molecular Mechanisms associated with the Cancer-Cachexia Syndrome Prof. Dr. Josep M. Argilés Department of Biochemistry & Molecular Biology University of Barcelona, Spain Disclosures: DANONE (Scientific
More informationMacro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease. T. Alp Ikizler, MD Vanderbilt University Medical Center
Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease T. Alp Ikizler, MD Vanderbilt University Medical Center Nutrition and Chronic Kidney Disease What is the disease itself and
More informationChronic Kidney Disease. Paul Cockwell Queen Elizabeth Hospital Birmingham
Chronic Kidney Disease Paul Cockwell Queen Elizabeth Hospital Birmingham Paradigms for chronic disease 1. Acute and chronic disease is closely linked 2. Stratify risk and tailor interventions around failure
More informationISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world
ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world Nutrition in Kidney Disease: How to Apply Guidelines to Clinical Practice? T. Alp
More informationTHE RELATIONSHIP BETWEEN MARKERS OF MALNUTRITION AND MUSCLE WASTING WITH FRAILTY AND PHYSICAL FUNCTION IN OLDER CARE HOME RESIDENTS
Journal of Aging Research & Clinical Practice Volume 6, 2017 J Aging Res Clin Practice 2017;6:176-181 Published online September 14, 2017, http://dx.doi.org/10.14283/jarcp.2017.23 THE RELATIONSHIP BETWEEN
More informationImplementation of Nutritional Assessment in practice; How do we get there? Wesley Visser, dietitian, PhD.
Implementation of Nutritional Assessment in practice; How do we get there? Wesley Visser, dietitian, PhD. Disclosure Disclosure interest speaker (potential) conflict of interest None Content History of
More informationOlder People with Complex Health Needs: NIHR Workshop Delegate Agenda The Royal Society 6-9 Carlton House Terrace London SW1Y 5AG
Older People with Complex Health Needs: NIHR Workshop Delegate Agenda The Royal Society 6-9 Carlton House Terrace London SW1Y 5AG Wednesday 2 nd November 2016 A workshop to identify tractable research
More informationStrategic Clinical Network for Yorkshire and the Humber
Strategic Clinical Network for Yorkshire and the Humber SCN-CVD-Nephrology-AKI John Stoves Park Plaza, Leeds 16 th June 2014 2 Strategic Clinical Networks SCNs operate as engines for change across complex
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationTHE UNIVERSITY of EDINBURGH
THE UNIVERSITY of EDINBURGH Professor Kenneth Fearon MB ChB(Hons), MD, FRCPS (Glasgow), FRCS (Edinburgh), FRCS (England) Memorial Cancer Cachexia Symposium Royal Society of Edinburgh, George Street, Edinburgh
More informationA tale of two specialties
A tale of two specialties United Kingdom Annual Symposia on Renal-Palliative Care co-organised by both disciplines National Service Framework for Renal Services Part 2 (UK) - 2005 Concentrated on the
More informationMalnutrition in the community everyone's responsibility?
Malnutrition in the community everyone's responsibility? Elizabeth Weekes PhD RD Consultant Dietitian and NIHR Clinical Lecturer Guy s & St Thomas NHS Foundation Trust King s College London Introduction
More informationActivity Report March 2013 February 2014
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland
More informationElevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
More informationRegional Follow-up Guidelines
Breast Cancer Managed Clinical Network Breast Cancer Regional Follow-up Guidelines Prepared by J McIlhenny/ I Reid Approved by Breast Cancer MCN Advisory Board/ RCCLG Issue date July 2017 Review date July
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic kidney disease: early identification and management of adults with chronic kidney disease in primary and secondary
More informationWith you for the journey
With you for the journey not just for the assessment With you every step of the way Score Score s Every journey begins with the first step The first movement FORWARD in the direction you want to travel
More informationThe Renal Association UK Renal Registry
The Renal Association UK Renal Registry Southmead Hospital Southmead Road Bristol BS10 5NB UK Telephone þ 44 (0) 117 323 5665 Fax þ 44 (0) 117 323 5664 Email renalreg@renalreg.com Web site www.renalreg.org
More informationChildren with non-oncological life-limiting conditions deserve the same high-quality palliative care as children with incurable cancer
Children with non-oncological life-limiting conditions deserve the same high-quality palliative care as children with incurable cancer Results of a retrospective case-notes audit Archana Soman Consultant
More informationCANCER CACHEXIA. Barry J A Laird Clinician Scientist in Palliative Medicine, University of Edinburgh & European Palliative Care Research Centre
CANCER CACHEXIA Barry J A Laird Clinician Scientist in Palliative Medicine, University of Edinburgh & European Palliative Care Research Centre Consultant in Palliative Medicine BWoSCC and Edinburgh Cancer
More information2010 National Audit of Dementia (Care in General Hospitals)
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: Barking, Havering and Redbridge Hospitals NHS Trust The 2010
More informationBritish Association of Stroke Physicians Strategy 2017 to 2020
British Association of Stroke Physicians Strategy 2017 to 2020 1 P age Contents Introduction 3 1. Developing and influencing local and national policy for stroke 5 2. Providing expert advice on all aspects
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationPalliative care competencies: is it for all? Khon Kaen International Conference in Palliative Care 2018
Palliative care competencies: is it for all? Khon Kaen International Conference in Palliative Care 2018 Definition Competence The ability to do something successfully or efficiently For us it means reaching
More informationINTEGRATED CARE. Table 1. RVCARE core components and goals. Figure 2. Patients who choose PD in the RVCARE Program
The first 120 days of crucial care: Strategies for managing incident dialysis patients Naveena Reddy, MS, RD Farzeen Sukheswalla, MS, RD George R. Aronoff, MD, MS, FACP. The Renal ACO New Approaches to
More informationSubmission on the General Scheme for Advance Healthcare Directives. for Incorporation into the Assisted Decision-Making (Capacity) Bill 2013
Submission on the General Scheme for Advance Healthcare Directives for Incorporation into the Assisted Decision-Making (Capacity) Bill 2013 March 2014 The Irish Heart Foundation (IHF) is the national charity
More informationHemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK
Hemodiafiltration: principles and advantages over conventional HD Rukshana Shroff Great Ormond Street Hospital for Children London, UK Effectiveness of RRT modalities Mcfarlane, Seminars in dialysis, 2009
More informationChronic Kidney Disease: Optimal and Coordinated Management
Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,
More informationEdward Jones, MD KCP Chairman Gail Wick, MHSA, BSN, RN, CNN Allen Nissenson, MD
Re-launching KCQA Edward Jones, MD KCP Chairman Gail Wick, MHSA, BSN, RN, CNN Allen Nissenson, MD ABOUT KCP Re-launching KCQA Founded in May 2003 Voice of the entire kidney care community Patients and
More informationMarginal Dialysis: Patient characteristics influencing outcomes
Marginal Dialysis: Patient characteristics influencing outcomes Dr Celine Foote Staff specialist, Concord Repatriation General Hospital Post-Doctoral Research Fellow, The George Institute for Global Health
More informationWith you for the journey
With you for the journey not just for the assessment With you every step of the way Expert s Every journey begins with the first step The first movement FORWARD in the direction you want to travel Not
More informationGeriatric Medicine I) OBJECTIVES
Geriatric Medicine I) OBJECTIVES 1 To provide a broad training and in-depth experience at a level sufficient for trainees to acquire competence and professionalism required of a specialist in Geriatric
More informationFrom Better to Best: Improving the availability of organs for transplant
From Better to Best: Improving the availability of organs for transplant Elisabeth Buggins CBE Strategy Oversight Group Chair Presentation outline Progress 2004-2014 Strategy and work underway Outcomes
More information